CONTACT US   |  (864) 397-5101

SCRA invests $200K in Duncan, S.C.-based Global Transplant Solutions

The South Carolina Research Authority’s S.C. Launch program has finalized a $200,000 investment for Global Transplant Solutions, a Duncan-based company that develops and distributes products for the human organ procurement and transplant marketplace.

The investment will be used to finalize global sales, develop proprietary products, and further the company’s research efforts, according to a news release.

“We are proud to partner with SC Launch and the state of South Carolina as we establish, build, and grow our worldwide organ transplant business,” said John Bruens, CEO of Global Transplant Solutions. “As a company exclusively focused on supporting the critical need for more donated organs and partnering with the dedicated professionals in this market who every day save countless lives around the world, Global Transplant Solutions Inc. is poised to position South Carolina as the epicenter for the advancement of transplant technologies, products, and policies.”

Global Transplant Solutions currently supplies products to the Canadian transplant market. The company has received clearance from the U.S. Food and Drug Administration (FDA) to distribute its first product in the United States and is awaiting FDA clearance for a second product.

The company also plans to gain clearance from the FDA for four additional products, which together will represent 99 percent of all organ preservation solutions used worldwide. It already has distribution agreements with several national and international partners, according to a news release.

“There is a worldwide demand for Global Transplant Solutions’ products, and to see the demand being fulfilled by a company in Duncan, S.C., is very exciting,” said Jill Sorensen, director of entrepreneurial programs at the South Carolina Research Authority (SCRA).

The SCRA is a state-chartered organization that fosters job creation and grows the innovation economy. The S.C. Launch program is the authority’s entrepreneurial platform that provides mentoring, grants, and investments to qualified companies in the advanced materials, information technology, and life sciences industries.

For more information, visit scra.org.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.